These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 15623625)
1. Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Fradet V; Lessard L; Bégin LR; Karakiewicz P; Masson AM; Saad F Clin Cancer Res; 2004 Dec; 10(24):8460-4. PubMed ID: 15623625 [TBL] [Abstract][Full Text] [Related]
2. Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases. Lessard L; Karakiewicz PI; Bellon-Gagnon P; Alam-Fahmy M; Ismail HA; Mes-Masson AM; Saad F Clin Cancer Res; 2006 Oct; 12(19):5741-5. PubMed ID: 17020979 [TBL] [Abstract][Full Text] [Related]
3. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy. Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876 [TBL] [Abstract][Full Text] [Related]
5. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. Swindle P; Eastham JA; Ohori M; Kattan MW; Wheeler T; Maru N; Slawin K; Scardino PT J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984 [TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients. Satoh T; Yang G; Egawa S; Addai J; Frolov A; Kuwao S; Timme TL; Baba S; Thompson TC Cancer; 2003 Mar; 97(5):1225-33. PubMed ID: 12599229 [TBL] [Abstract][Full Text] [Related]
8. Impact of patient age on biochemical recurrence rates following radical prostatectomy. Magheli A; Rais-Bahrami S; Humphreys EB; Peck HJ; Trock BJ; Gonzalgo ML J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723 [TBL] [Abstract][Full Text] [Related]
9. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer? Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328 [TBL] [Abstract][Full Text] [Related]
10. Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence. Jones TD; Koch MO; Lin H; Cheng L BJU Int; 2005 Dec; 96(9):1253-7. PubMed ID: 16287440 [TBL] [Abstract][Full Text] [Related]
11. Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy? Jones TD; Koch MO; Bunde PJ; Cheng L BJU Int; 2006 Mar; 97(3):480-4. PubMed ID: 16469012 [TBL] [Abstract][Full Text] [Related]
12. Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer. Gannon PO; Lessard L; Stevens LM; Forest V; Bégin LR; Minner S; Tennstedt P; Schlomm T; Mes-Masson AM; Saad F Eur J Cancer; 2013 Jul; 49(10):2441-8. PubMed ID: 23541563 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Kausik SJ; Blute ML; Sebo TJ; Leibovich BC; Bergstralh EJ; Slezak J; Zincke H Cancer; 2002 Sep; 95(6):1215-9. PubMed ID: 12216087 [TBL] [Abstract][Full Text] [Related]
14. CD10 is inversely associated with nuclear factor-kappa B and predicts biochemical recurrence after radical prostatectomy. Voutsadakis IA; Vlachostergios PJ; Daliani DD; Karasavvidou F; Kakkas G; Moutzouris G; Melekos MD; Papandreou CN Urol Int; 2012; 88(2):158-64. PubMed ID: 22286396 [TBL] [Abstract][Full Text] [Related]
15. Expression of potential molecular markers in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Miyake H; Muramaki M; Kurahashi T; Takenaka A; Fujisawa M Urol Oncol; 2010; 28(2):145-51. PubMed ID: 18848789 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342 [TBL] [Abstract][Full Text] [Related]
17. Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database. Buschemeyer WC; Hamilton RJ; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Freedland SJ J Urol; 2008 Jan; 179(1):124-9; discussion 129. PubMed ID: 17997433 [TBL] [Abstract][Full Text] [Related]